Literature DB >> 13680033

Identification of CYP2D6 alleles by single nucleotide polymorphism analysis using pyrosequencing.

Anna-Lena Zackrisson1, Bertil Lindblom.   

Abstract

OBJECTIVE: To develop a single nucleotide polymorphism (SNP) analysis for identification of cytochrome P450 (CYP)2D6 alleles by pyrosequencing.
METHODS: Swedish blood donors ( n=282) were typed for a partial CYP2D6 genotype comprising the alleles *1 (wild type), *2 (2850C>T), *3 (2549A>del), *4 (1846G>A) and *6 (1707T>del) using polymerase chain reaction (PCR) and pyrosequencing analysis. CYP2D6*5 (CYP2D6 deleted) was identified using an established long multiplex PCR method. Pyrosequencing is a sequencing-by-synthesis method in which a cascade of enzymatic reactions yields detectable light, which is proportional to the incorporated nucleotides. One feature of typing SNPs by pyrosequencing is that each allelic variant will give a unique sequence. These variants can be readily distinguished by pattern recognition software.
RESULTS: Of 281 individuals analysed, 24 (8.5%) were found to be poor metabolisers with two non-functional alleles. This is in the range of 7-10%, previously reported for Caucasians. A total of 126 individuals (45%) had one functional and one non-functional allele and 131 individuals (47%) had two functional alleles.
CONCLUSION: Pyrosequencing was found to be a fast and efficient tool for genotyping. The method is robust, reliable, rapid and has high throughput.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680033     DOI: 10.1007/s00228-003-0654-7

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  Direct analysis of single-nucleotide polymorphism on double-stranded DNA by pyrosequencing.

Authors:  T Nordström; M Ronaghi; L Forsberg; U de Faire; R Morgenstern; P Nyrén
Journal:  Biotechnol Appl Biochem       Date:  2000-04       Impact factor: 2.431

2.  Single-nucleotide polymorphism analysis by pyrosequencing.

Authors:  A Ahmadian; B Gharizadeh; A C Gustafsson; F Sterky; P Nyrén; M Uhlén; J Lundeberg
Journal:  Anal Biochem       Date:  2000-04-10       Impact factor: 3.365

3.  Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiplex long PCR.

Authors:  M Hersberger; J Marti-Jaun; K Rentsch; E Hänseler
Journal:  Clin Chem       Date:  2000-08       Impact factor: 8.327

Review 4.  Polymorphisms of oxidation at carbon centers of drugs and their clinical significance.

Authors:  J R Idle; R L Smith
Journal:  Drug Metab Rev       Date:  1979       Impact factor: 4.518

5.  A fast method for high-quality genomic DNA extraction from whole human blood.

Authors:  S Gustincich; G Manfioletti; G Del Sal; C Schneider; P Carninci
Journal:  Biotechniques       Date:  1991-09       Impact factor: 1.993

6.  Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification.

Authors:  M Heim; U A Meyer
Journal:  Lancet       Date:  1990-09-01       Impact factor: 79.321

7.  Real-time DNA sequencing using detection of pyrophosphate release.

Authors:  M Ronaghi; S Karamohamed; B Pettersson; M Uhlén; P Nyrén
Journal:  Anal Biochem       Date:  1996-11-01       Impact factor: 3.365

8.  Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes.

Authors:  E Lundqvist; I Johansson; M Ingelman-Sundberg
Journal:  Gene       Date:  1999-01-21       Impact factor: 3.688

9.  Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.

Authors:  C Sachse; J Brockmöller; S Bauer; I Roots
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

10.  Drug-metabolizing enzymes and therapeutic drug monitoring in psychiatry.

Authors:  K Brøsen
Journal:  Ther Drug Monit       Date:  1996-08       Impact factor: 3.681

View more
  6 in total

1.  CYP1A1 genotype modifies the impact of smoking on effectiveness of HAART among women.

Authors:  David N Feldman; Joseph G Feldman; Ruth Greenblatt; Kathryn Anastos; Leigh Pearce; Mardge Cohen; Stephen Gange; Suzanne Leanza; Robbie Burk
Journal:  AIDS Educ Prev       Date:  2009-06

2.  Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians.

Authors:  Kevin C Brown; Mina C Hosseinipour; Janelle M Hoskins; Ranjit K Thirumaran; Hsiao-Chuan Tien; Ralf Weigel; Jean Tauzie; Ida Shumba; Jatinder K Lamba; Erin G Schuetz; Howard L McLeod; Angela D M Kashuba; Amanda H Corbett
Journal:  Pharmacogenomics       Date:  2011-11-23       Impact factor: 2.533

3.  Risperidone plasma levels, clinical response and side-effects.

Authors:  Michael Riedel; M J Schwarz; M Strassnig; I Spellmann; A Müller-Arends; K Weber; J Zach; N Müller; H J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-29       Impact factor: 5.270

4.  Influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition in patients with end-stage renal disease.

Authors:  Hadi Molanaei; Juan Jesus Carrero; Olof Heimbürger; Louise Nordfors; Bengt Lindholm; Peter Stenvinkel; Ingegerd Odar-Cederlöf; Leif Bertilsson
Journal:  Eur J Clin Pharmacol       Date:  2009-11-26       Impact factor: 2.953

5.  Fatal intoxication cases: cytochrome P450 2D6 and 2C19 genotype distributions.

Authors:  A L Zackrisson; P Holmgren; A B Gladh; J Ahlner; B Lindblom
Journal:  Eur J Clin Pharmacol       Date:  2004-09-02       Impact factor: 2.953

6.  Influence of CYP2D6 and CYP2C19 genotypes on venlafaxine metabolic ratios and stereoselective metabolism in forensic autopsy cases.

Authors:  L Karlsson; A-L Zackrisson; M Josefsson; B Carlsson; H Green; F C Kugelberg
Journal:  Pharmacogenomics J       Date:  2014-09-23       Impact factor: 3.550

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.